SCHEMBL9958680

SCHEMBL9958680

CC(=O)NOc1ccccc1-c1nccs1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
HPGD P15428 1/20 0.42
AHR P35869 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.41
SLC6A9 P48067 1/20 0.40
S1PR1 P21453 1/20 0.40
MAPK1 P28482 2/20 0.40
ALOX15 P16050 1/20 0.40
PDPK1 O15530 1/20 0.39
HDAC2 Q92769 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4466164 0.78 ADRA1D (0.47) ADRA1DADRA1AADRA1BNPC1RAB9A
Water SCHEMBL27443194 0.78 ADRA1D (0.44) ADRA1DADRA1AADRA1BNPC1RAB9A
SCHEMBL7470034 0.76 PTGDR2 (0.53) ADRA1DADRA1AADRA1BNPC1RAB9A
SCHEMBL5396495 0.76 ADRA1D (0.52) ADRA1DADRA1AADRA1BNPC1RAB9A
SCHEMBL29715238 0.76 ADRA1D (0.52) ADRA1DADRA1AADRA1BNPC1RAB9A
SCHEMBL28579044 0.75 ADRA1A (0.55) ADRA1DADRA1AADRA1BRAB9APTGDR2
Acetic Acid SCHEMBL7297431 0.75 HDAC2 (0.49) NPC1RAB9AALDH1A1TP53HPGD
SCHEMBL7475116 0.74 PTGDR2 (0.68) ADRA1DADRA1AADRA1BKDM4EALDH1A1
SCHEMBL28304414 0.73 ADRA1A (0.57) ADRA1DADRA1AADRA1BRAB9ATP53
SCHEMBL29364998 0.73 KDM4E (0.57) NPC1RAB9AKDM4EALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125735-B1 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LTD (IN) 2012-06-27 EP disclosed